Cow's milk and hen's egg anaphylaxis: A comprehensive data analysis from the European Anaphylaxis Registry.

Journal Information

Full Title: Clin Transl Allergy

Abbreviation: Clin Transl Allergy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability statement anonymized data are available under osf accession number: doi 10 17605/osf io/kcdw9 . data availability statement anonymized data are available under osf"

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT ECJ serves as ALK paediatric advisory board, AK got personal fees (advisory board) from Allergopharma and Menarini AG, travel grant from Stallergenes, JO’BH receives research funding, speaker fees and consultancy fees from Aimmune Therapeutics, research funding and speaker fees from DBV Technologies, and research funding from Johnson&Johnson, Clemens von Pirquet Foundation, Temple St Hospital Foundation and City of Dublin Skin and Cancer Hospital Charity, KN was paid Nutricia/Danone and AimmuneTherapeutics in the past 3 years, other co‐authors declare no conflict of interest."

Evidence found in paper:

"We would like to thank all of the parents and their children for their support in providing data. We would also like to thank the study personnel for their patient counselling and data entry: P. Brzyski (Kraków, Poland), A. Knapp (Kraków, Poland), J. Grünhagen, V. Höfer (Berlin, Germany), K. Beyer (Berlin, Germany), A. Möser (Jena, Germany), F. Rueff (Munich, Germany), B. Wedi (Hanover, Germany), H. Dickel (Bochum, Germany), A. Bauer (Dresden, Germany), N. Wagner (Erlangen, Germany), E. Rietschel (Cologne, Germany), R. Treudler, S. Aurich (Leipzig, Germany), N. Reider (Innsbruck, Austria), W. Aberer (Graz, Austria), K. Hartmann (Basel, Switzerland), F. Riffelmann (Schmallenberg, Germany), B. Kreft (Halle, Germany), T. Kinaciyan (Vienna, Austria), J. Witte (Hamburg, Germany), U. Rabe (Treuenbritzen, Germany), P. Schmid‐Grendelmeier (Zurich, Switzerland), S. Nestoris (Lippe‐Lemgo, Germany), T. Hawranek and R. Lang (Salzburg, Austria), G. Hansen (Hanover, Germany), C. Pföhler (Homburg, Germany), Z. Szepfalusi (Vienna, Austria), P. Eng (Aarau, Switzerland), T. Reese (Rheine, Germany), M. Polz (Rüsselsheim, Germany), G. Stichtenoth (Lübeck, Germany), S. Thies (Schwedt, Germany), I. Yildiz (Neumünster, Germany), M. Gerstlauer (Augsburg, Germany), A. Nordwig (Dresden, Germany), P. Utz (Wangen im Allgäu, Germany), J. Klinge (Fürth, Germany), J. Fischer (Tübingen, Germany), A. Henschel (Berlin, Germany), S. Plank‐Habibi (Alzenau, Germany), B. Schilling (Passau, Germany), A. Kleinheinz, A. Brückner (Buxtehude, Germany), K. Schäkel (Heidelberg, Germany), M. Kowalski† (Lodz, Poland), M. Fernandez‐Rivas (Madrid, Spain), K. Solarewicz‐Madajek (Wroclaw, Poland), C. Körner‐Rettberg (Bochum, Germany), S. Tscheiller and all members of the Allergy Vigilance Network (France), T. Mustakov (Sofia, Bulgaria), C. Kemen (Hamburg, Germany), F. Prenzel (Leipzig, Germany), C. Ebner (Vienna, Austria), J. Seidenberg, H. Köster (Oldenburg, Germany), V. Cardona (Barcelona, Spain), S. Hämmerling (Heidelberg, Germany), B. Garcia (Pamplona, Spain), M. Bilo (Ancona, Italy), N. Cabañes Higuero (Toledo, Spain), A. Vega Castro (Guadalajara, Spain), I. Poziomkowska‐Gęsicka (Szczecin, Poland), S. Büsing (Osnabrück, Germany), U. Staden (Berlin, Germany), C. Virchow (Rostock, Germany), G. Christoff (Sofia, Bulgaria), U. Jappe (Borstel, Germany), S. Müller (Freiburg, Germany), H. Straube (Darmstadt, Germany), F. Knöpfel (Norderney, Germany), I. Maris (Cork, Ireland), B. Rogala (Silesia, Poland), T. de Vincente (Madrid, Spain), A. Muraro (Padua, Italy), T. Buck und J. Büsselberg (Hanover‐Misburg, Germany), N. Zimmermann (Potsdam, Germany), D. Hernandez (Valencia, Spain), P. Minale (Genua, Italy), S. Altrichter (Linz, Austria), A. Reissig (Gera, Germany), F. Horak (Vienna, Austria), R. Asero (Milan, Italy), F. Hermann, S. Zeidler (St. Augustin, Germany), S. Pistauer (Sylt/Westerland, Germany), A. Plaza Martin (Barcelona, Spain), J. Meister (Aue, Germany), P. Stock (Hamburg, Germany), E. Hamelmann (Bielefeld, Germany), I. Neustädter (Nuremberg, Germany), A. Fiocchi, S. Arasi (Rome, Italy), Fabiana Andrade Nunes Oliveira, Bárbara Cristina Ferreira Ramos (São Paulo, Brazil), ALisa Arens, Rebecca Drägerdt, SAnna Hoffmann (Hamburg, Germany), Bettina Bogatu (Zürich, Switzerland), P. Xepapadaki, M. Kritikou (Athens, Greece), Sunhild Gernert (Bonn, Germany). The Anaphylaxis Registry was supported by the Network for Online Registration of Anaphylaxis NORA e.V. Partially funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the clinical research unit (CRU339): Food allergy and tolerance (FOOD@) – 409,525,714 and by the German Federal Ministry of Education and Research (BMBF; 01KU2005 and 01EA2107 B)."

Evidence found in paper:

"Data used in the current analysis come from tertiary referral centres specializing in paediatric allergology, dermatology, or both, in Germany, France, Austria, Switzerland, Spain, Greece, Italy, Ireland, Bulgaria, Poland, and Brazil (Figure S1). Professionals at the referral centres were required to enter the patients' details into the registry within 1 year of their anaphylaxis episode. The study was registered at ClinicalTrials.gov (Identifier: NCT05210543), and it was approved by both the ethics committee at the Charité ‐ Universitätsmedizin Berlin, in Germany (EA1/079/06), as well as the ethics committees local to the participating referral centres."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025